ArticleBiomedicines2025

Carbon Footprint Impact, of Monoclonal Antibodies for Severe Asthma, Administered in Italy.

Diego Bagnasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.